Search results
Results from the WOW.Com Content Network
Medical Marijuana and Cannabidiol Research Expansion Act; Long title: To expand research on cannabidiol and marijuana, and for other purposes. Enacted by: the 117th United States Congress: Effective: December 2, 2022: Citations; Public law: Pub. L. 117–215 (text) Statutes at Large: 136 Stat. 2257: Legislative history
California Cannabis Research Medical Group; Cannabis Action Network; Cannabis Law Reform; Coalition for Rescheduling Cannabis; Doctors for Cannabis Regulation; Drug Policy Alliance; Green Panthers; Law Enforcement Action Partnership; Marijuana Policy Project; Medical Marijuana Assistance Program of America; Multidisciplinary Association for ...
Was the Department of Health Division of Medical Marijuana and Integrative Therapy until October 1, 2020; [6] medical cannabis only – there is no regulatory agency for other use. [a] Puerto Rico Medical Cannabis Regulatory Board (a division of the Puerto Rico Department of Health). The Board was created in 2017 under the MEDICINAL Act of 2017 ...
Richard Cowan: Former National Director of NORML. Member of the Advisory Board of the Drug Policy Foundation. Senior Policy Advisor to NORML. Editor and Publisher, marijuananews. Ed Rosenthal: He has written and edited more than a dozen books about marijuana cultivation and social policy.
As of April 2023, 38 states, 3 territories, and Washington, D.C. have legalized the use of medical marijuana. [7] At a congressional hearing in June 2014, the deputy director for Regulatory Programs at the FDA said the agency was conducting an analysis on whether marijuana should be downgraded, at the request of the DEA. [8]
The maximum THC threshold for college athletes in mandatory drug tests had been 35 nanograms per milliliter. ... Students who test positive for marijuana under the new rules are also able to keep ...
Research on the medical benefits of cannabis has been hindered by various federal regulations, including its Schedule I classification. [3] To conduct research on cannabis, approval must be obtained from the Food and Drug Administration, [4] and a license must be obtained from the Drug Enforcement Administration specific to Schedule I drugs. [5]
Adjusts Legal CBD On January 20, Idaho SB1017 was introduced to raise the allowable THC level in legal cannabidiol (CBD) products from 0% [36] to 0.1% THC. [37] The bill was signed into law on February 26, 2021. Effective July 1, 2021. Idaho Medical Marijuana Act: Initiative February 11, 2021: Medical